Light Street Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,191,872
Closed -$19.6M 31
2022
Q3
$19.6M Sell
4,191,872
-437,404
-9% -$2.76M 4.98% 8
2022
Q2
$27.4M Buy
4,629,276
+420,123
+10% +$4.68M 2.24% 10
2022
Q1
$81.4M Buy
4,209,153
+2,784,779
+196% +$63.9M 5.27% 3
2021
Q4
$46.5M Sell
1,424,374
-592,930
-29% -$23.9M 2.78% 16
2021
Q3
$82.8M Buy
2,017,304
+585,005
+41% +$21.2M 4.15% 6
2021
Q2
$51.6M Sell
1,432,299
-113,701
-7% -$4.2M 2.24% 16
2021
Q1
$60.3M Sell
1,546,000
-484,847
-24% -$21.8M 3.23% 10
2020
Q4
$81.9M Buy
2,030,847
+252,847
+14% +$11.6M 2.44% 13
2020
Q3
$98.9M Buy
+1,778,000
New +$94.1M 3.11% 4

Other funds holding GDRX

Light Street Capital Management's GDRX Position: Q4 2022 in Review

Light Street Capital Management sold out of GoodRx Holdings (GDRX) in Q4 2022, closing a stake of 4,191,872 shares — an estimated $19.6M sold.

Light Street Capital Management first reported a position in GDRX in Q3 2020 and held it in 9 quarters. The position peaked at $98.9M in Q3 2020. 160 funds tracked by Wall St. Rank hold GDRX as of Q4 2022.

  • Light Street Capital Management reported no remaining GoodRx Holdings position as of Q4 2022 after selling out during the quarter.
  • Light Street Capital Management sold 4,191,872 GoodRx Holdings shares in Q4 2022, an estimated $19.6M.
  • Light Street Capital Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 9 quarters.
  • Light Street Capital Management's GoodRx Holdings position peaked at $98.9M in Q3 2020.
  • 160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2022.

Based on Light Street Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.